Quinazoline derivatives as RAF kinase modulators and methods of use thereof

Details for Australian Patent Application No. 2009226136 (hide)

Owner Ambit Biosciences Corporation

Inventors Setti, Eduardo; Rowbottom, Martin W.; Holladay, Mark W.; Faraoni, Raffaella; Chao, Qi; Lai, Andiliy G.; Abraham, Sunny; Bhagwat, Shripad; Campbell, Brian T.; Sprankle, Kelly G.

Agent Watermark

Pub. Number AU-A-2009226136

PCT Pub. Number WO2009/117080

Priority 61/069,763 17.03.08 US; 61/110,508 31.10.08 US

Filing date 17 March 2009

Wipo publication date 24 September 2009

International Classifications

C07D 239/88 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/93 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

7 October 2010 PCT application entered the National Phase

  PCT publication WO2009/117080 Priority application(s): WO2009/117080

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009226141-Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase

2009226135-Rapid localized language development for video matrix switching system